NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 14 filers reported holding NEVRO CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 42,000,000 | $39,609,000 | 0.79% |
| WOLVERINE ASSET MANAGEMENT LLC | 47,866,000 | $45,100,000 | 0.49% |
| Context Capital Management, LLC | 7,689 | $7,201,000 | 0.48% |
| PFM Health Sciences, LP | 9,000,000 | $8,519,000 | 0.31% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,534,000 | $1,446,000 | 0.04% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,667,000 | $5,364,000 | 0.03% |
| Rock Springs Capital Management LP | 500,000 | $473,000 | 0.01% |
| BNP PARIBAS FINANCIAL MARKETS | 28,872 | $1,345,435,000 | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 0 | $946,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 701,000 | $659,124,000 | 0.00% |